In a 42‑year‑old man who abruptly reduced bromazepam (benzodiazepine) from about 6 mg to 0.25 mg and now has vertigo likely from citalopram discontinuation, is it safe to simply wait for the dizziness to resolve on its own (self‑limiting within 1–2 weeks) without adjusting the benzodiazepine taper?

No, it is not safe to simply wait for the dizziness to resolve without adjusting the benzodiazepine taper

This patient requires immediate stabilization of his benzodiazepine dose before addressing the citalopram discontinuation symptoms. The abrupt reduction from 6 mg to 0.25 mg bromazepam represents a dangerous 96% dose reduction that carries serious risks including seizures, delirium, hallucinations, and in rare cases, death 1.

Critical Safety Concerns

Benzodiazepine Withdrawal Takes Priority

The CDC guidelines explicitly state that benzodiazepine withdrawal carries greater risks than opioid withdrawal and that abrupt withdrawal can be associated with rebound anxiety, hallucinations, seizures, delirium tremens, and death 1. This patient's taper was far too aggressive—going from 6 mg to 0.25 mg is essentially an abrupt discontinuation, not a gradual taper.

The recommended safe taper is 25% of the daily dose every 1-2 weeks 1, 2. This patient should have reduced by approximately 1.5 mg every 1-2 weeks, not jumped to 0.25 mg. The current dose needs to be increased back to a safer level immediately.

Distinguishing Withdrawal Syndromes

While the citalopram discontinuation syndrome does cause dizziness, vertigo, sensory disturbances, and other symptoms that are "generally self-limiting" 3, you cannot safely observe these symptoms when the patient is simultaneously at high risk for benzodiazepine withdrawal complications. The vertigo could represent:

• Citalopram discontinuation (typically self-limiting within 1-2 weeks) 3, 4
• Early benzodiazepine withdrawal (potentially life-threatening)
• Both syndromes overlapping

The stakes are too high to assume this is only citalopram-related dizziness.

Immediate Management Algorithm

1. Increase bromazepam immediately to at least 4.5 mg daily (75% of original dose)
2. Monitor for severe withdrawal signs: confusion, hallucinations, tremor, seizure activity, autonomic instability
3. Once stabilized on benzodiazepine, address the citalopram discontinuation symptoms
4. Restart proper benzodiazepine taper: reduce by 1.5 mg every 1-2 weeks, or slower if withdrawal symptoms emerge 1

Why This Approach

The evidence is clear that tapers slower than 10% per week may be better tolerated, particularly for long-term users 5. Some experts recommend reductions as slow as 10% per month 5. At very low doses, even smaller reductions may be necessary—as little as 0.2 mg equivalents for the final steps 6.

Addressing the Citalopram Component

Once the benzodiazepine is stabilized, the citalopram discontinuation symptoms can be managed. The FDA label confirms these symptoms are "generally self-limiting" 3, but if intolerable, resuming the previously prescribed citalopram dose should be considered, followed by a more gradual taper 3.

Citalopram discontinuation syndrome includes dizziness, vertigo, sensory disturbances, anxiety, and irritability 7. These symptoms arise from abrupt serotonin changes in the vestibular nucleus complex 4. However, unlike benzodiazepine withdrawal, citalopram discontinuation is not life-threatening.

Common Pitfalls to Avoid

• Never assume dizziness is benign in a patient who just drastically reduced benzodiazepines
• Do not continue aggressive benzodiazepine tapers when withdrawal symptoms appear—pause and potentially increase the dose 5
• Avoid vestibular suppressants (antihistamines, benzodiazepines) if true BPPV is suspected, as they are ineffective and delay proper treatment 8, 9
• Remember that clonidine or other sympatholytics can mask benzodiazepine withdrawal by suppressing autonomic hyperarousal 10

Long-term Plan

After stabilization:

• Resume benzodiazepine taper at 25% reductions every 1-2 weeks minimum 1
• Consider even slower tapers (10% per month) given the initial aggressive reduction 5
• At doses below 1 mg, use liquid formulations or compounded preparations to make tiny reductions 6
• If citalopram needs to be restarted, taper it separately and more gradually 3

The answer to "is it safe to wait" is definitively no. The benzodiazepine dose must be adjusted upward immediately to prevent potentially fatal withdrawal complications. Only after stabilization can you determine whether residual dizziness represents self-limiting citalopram discontinuation effects.